MRI of paediatric liver tumours: How we review and report
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Aug 2016 · 1 min read
In brief
In brief
This review provides radiologists with a practical framework for MRI evaluation of pediatric liver masses, emphasizing sequence selection and contrast agent use to differentiate benign lesions from malignancies. The article details imaging features of hepatoblastoma and hepatocellular carcinoma while addressing common diagnostic mimickers like FNH and adenomas.
Written by the GCMD Library team from the article.
Statements in this article
Benign liver tumours such as haemangiomas and cystic mesenchymal hamartomas are typically seen in infancy, often before 6 months of age.
After 6 months of age, malignant hepatic tumours increase in frequency.
Differentiation of a malignant from benign lesion on imaging can often negate the need for biopsy.
Ultrasound is currently the main screening tool for suspected liver pathology in children.
MRI is now the modality of choice for further characterisation of hepatic mass lesions in children.